Detalhe da pesquisa
1.
Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction.
Am Heart J
; 159(3): 354-60, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211295